Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 45

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 45
---
 be harmed.

In addition to patent protection,
we also rely on protection of copyright, trade secrets, know-how and confidential and proprietary information. We generally enter into
confidentiality and invention assignment agreements with our employees, consultants and third parties upon their commencement of a relationship
with us. However, we may not enter into such agreements with all employees, consultants and third parties who have been involved in the
development of our intellectual property. In addition, these agreements may not provide meaningful protection against the unauthorized
use or disclosure of our trade secrets or other confidential information, and adequate remedies may not exist if unauthorized use or
disclosure were to occur. The exposure of our trade secrets and other proprietary information would impair our competitive advantages
and could have a material adverse effect on our business, financial condition and results of operations. In particular, a failure to
protect our proprietary rights may allow competitors to copy our products and procedures, which could adversely affect our pricing and
market share. Further, other parties may independently develop substantially equivalent know-how and technology.

<div align='center'>32</div>

In addition to contractual
measures, we try to protect the confidential nature of our proprietary information using commonly accepted physical and technological
security measures. Such measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party
with authorized access, provide adequate protection for our proprietary information. Our security measures may not prevent an employee
or consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct
may not provide an adequate remedy to protect our interests fully. Unauthorized parties may also attempt to copy or reverse engineer
certain aspects of our products that we consider proprietary. Enforcing a claim that a party illegally disclosed or misappropriated a
trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. Even though we use commonly accepted security
measures, trade secret violations are often a matter of state law, and the criteria for protection of trade secrets can vary among different
jurisdictions. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us.
While we have agreements with our employees, consultants and third parties that obligate them to assign their inventions to us, these
agreements may not be self-executing, not all employees or consultants may enter into such agreements, or employees or consultants may
breach or violate the terms of these agreements, and we may not